• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胎儿21三体综合征风险增加的妊娠选择策略]

[Strategies for selection of pregnancies with increased risk of fetal trisomy 21].

作者信息

Boué A, Muller F

机构信息

Inserm U 73 Château de Longchamp, Paris, France.

出版信息

Pediatrie. 1991;46(6-7):527-32.

PMID:1664086
Abstract

The main indications for cytogenetic prenatal diagnosis have been based on pregnancies with an increased risk of chromosomal anomaly. Advanced maternal age has been the most important criterion and presently 60% of women of 38 yr and over undergo prenatal diagnosis. Fetal malformations detected by ultrasound resulted in the selection of a group in which approximately 10% chromosomal anomalies were detected. An effort has been made to describe sonographic signs indicative of Down's syndrome. Maternal serum biochemical markers constitute another approach for screening. Human chorionic gonadotropin is the most discriminant test. Combining maternal and hCG cut-off levels, it is possible to detect approximately 70% of trisomy 21% in women aged between 30-38 yr.

摘要

细胞遗传学产前诊断的主要指征基于染色体异常风险增加的妊娠情况。高龄产妇一直是最重要的标准,目前38岁及以上的女性中有60%接受产前诊断。超声检测出的胎儿畸形导致了一个群体的选择,其中大约10%检测出染色体异常。人们一直在努力描述提示唐氏综合征的超声征象。孕妇血清生化标志物是另一种筛查方法。人绒毛膜促性腺激素是最具鉴别力的检测指标。结合孕妇和人绒毛膜促性腺激素的临界值水平,可以在30至38岁的女性中检测出约70%的21三体综合征。

相似文献

1
[Strategies for selection of pregnancies with increased risk of fetal trisomy 21].[胎儿21三体综合征风险增加的妊娠选择策略]
Pediatrie. 1991;46(6-7):527-32.
2
Prenatal screening for Down's syndrome with use of maternal serum markers.使用母体血清标志物进行唐氏综合征的产前筛查。
N Engl J Med. 1992 Aug 27;327(9):588-93. doi: 10.1056/NEJM199208273270902.
3
Antenatal screening for Down's syndrome: where are we and where next?唐氏综合征的产前筛查:我们目前的状况及下一步走向何方?
Lancet. 1998 Aug 1;352(9125):336-7. doi: 10.1016/S0140-6736(98)22031-9.
4
[Detection of chromosomal abnormalities using cordocentesis].[利用脐带穿刺术检测染色体异常]
Genetika. 1991 Aug;27(8):1481-5.
5
Antenatally detectable markers for the diagnosis of autosomally trisomic fetuses in at-risk pregnancies.用于诊断高危妊娠中常染色体三体胎儿的产前可检测标志物。
Am J Perinatol. 1997 May;14(5):257-61. doi: 10.1055/s-2007-994139.
6
Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.孕中期唐氏综合征筛查项目中联合母体血清甲胎蛋白和人绒毛膜促性腺激素的有效性。
Obstet Gynecol. 1994 Aug;84(2):298-303.
7
Antenatal maternal serum profiles.产前母体血清谱。
Br J Hosp Med. 1994;51(5):243-6.
8
[Maternal serum markers of fetal trisomy 21].[胎儿21三体综合征的母体血清标志物]
Presse Med. 1995 Sep 23;24(27):1265-9.
9
Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.使用母体血清甲胎蛋白、人绒毛膜促性腺激素和未结合雌三醇进行产前筛查:在一家健康维护组织中的两年经验。
J Matern Fetal Med. 1996 Mar-Apr;5(2):70-3. doi: 10.1002/(SICI)1520-6661(199603/04)5:2<70::AID-MFM4>3.0.CO;2-N.
10
Seeking other disorders within antenatal serum screening programmes for Down's syndrome.
J Med Screen. 2002;9(4):145-6. doi: 10.1136/jms.9.4.145.